31 December 2021
Roquefort Therapeutics plc
("Roquefort Therapeutics" or the "Company")
Change of Company Name
Roquefort Therapeutics (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the biotechnology sector , is pleased to announce that the company name of Roquefort Investments plc has changed to Roquefort Therapeutics plc. The Company's ordinary shares will continue to trade under the ticker ROQ, ISIN GB00BMDQ2T15 and SEDOL code BMDQ2T1.
No action from shareholders is required in relation to the change.
Enquiries:|
Roquefort Therapeutics plc |
|
|
Stephen West (Chairman) |
+44 (0)20 3290 9339 |
|
Buchanan (Public Relations) Ben Romney / Jamie Hooper / George Beale Optiva Securities Limited (Broker) |
+44 (0)20 7466 5000 |
|
Christian Dennis |
+44 (0)20 3411 1881 |
For further information, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.
LEI: 254900P4SISIWOR9RH34
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.